Source: Annual Congress 2001 - OSA and other sleep related breathing disorders: epidemiology, diagnosis, treatment



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Peker, J. Norum, J. Hedner, J. Carlson (Gothenburg, Sweden). Increased cardiovascular mortality in obstructive sleep apnoea: a 7-year follow-up. Eur Respir J 2001; 16: Suppl. 31, 2358

Member's Comments

No comment yet.

Related content which might interest you: Obstructive sleep apnea is a risk factor for death in stroke patients – a 10-year follow-up Source: Eur Respir J 2007; 30: Suppl. 51, 328s Year: 2007 Mortality and morbidity in obstructive sleep apnoea–hypopnoea syndrome: results from a 30-year prospective cohort study Source: ERJ Open Res, 6 (3) 00057-2020; 10.1183/23120541.00057-2020 Year: 2020 Obstructive sleep apnoea and risk of cardiovascular disease in men. A follow-up study Source: Eur Respir J 2003; 22: Suppl. 45, 22s Year: 2003 Increased incidence of coronary artery disease in obstructive sleep apnoea: a seven-year follow-up Source: Eur Respir J 2001; 18: Suppl. 33, 518s Year: 2001 Impact of obstructive sleep apnea and CPAP treatment on mortality and cardio and cerebrovascular consequences in men of the general population after 20 years of follow-up. Source: Virtual Congress 2020 – From pathophysiology to clinical consequences of sleep and breathing disorders Year: 2020 Obstructive sleep apnoea doesn‘t increase risk of cardiovascular morbidity and mortality in patients with arterial hypertension Source: Annual Congress 2008 - Socioepidemiological studies in obstructive sleep apnoea Year: 2008 Cardiovascular morbidity and mortality in patients with obstructive sleep apnea - a prospective study Source: Annual Congress 2005 - What should we know about our SAS patients Year: 2005 Is there a gender difference in cardiovascular mortality in obstructive sleep apnoea? Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009 Cardiovascular morbidity and obstructive sleep apnoea in children Source: Annual Congress 2009 - Current developments in sleep-disordered breathing in children Year: 2009 Cardiovascular morbidity in obstructive sleep apnoea Source: Annual Congress 2009 - PG5 Core Curriculum Postgraduate Course: Obstructive sleep apnoea – current pathophysiological, clinical and therapeutic concepts Year: 2009 Mortality in sleep apnoea syndrome: a review of the evidence Source: Eur Respir Rev 2007; 16: 203-210 Year: 2007 Treatment of obstructive sleep apnea improves cardiovascular outcome. A prospective study Source: Eur Respir J 2006; 28: Suppl. 50, 817s Year: 2006 Physical activity in obstructive sleep apnea (OSA) patients with high cardiovascular risk Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise Year: 2010 Diet and exercise in the management of obstructive sleep apnoea and cardiovascular disease risk Source: Eur Respir Rev, 26 (144) 160110; 10.1183/16000617.0110-2016 Year: 2017 Effects of an oral appliance on obstructive sleep apnoea: a 2-year follow-up Source: Eur Respir J 2001; 18: Suppl. 33, 419s Year: 2001 Evaluation of cardiovascular risk after long-term c-PAP therapy in patients with obstructive sleep apnea. A 4-year follow-up Source: International Congress 2015 – Innovations in noninvasive ventilation: is it always gold that glitters? Year: 2015 Cardiac troponin I levels and relationship with cardiovascular morbidity in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 38s Year: 2005 Predictors of long-term PAP-adherence in obstructive sleep apnea syndrome Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 Incidence of cardiovascular complications in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007